Indaptus Therapeutics, Inc. (INDP)
1.15
+0.02
(+1.77%)
USD |
NASDAQ |
Sep 02, 14:36
Indaptus Therapeutics Total Assets (Quarterly) : 11.99M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.99M |
| March 31, 2026 | 2.181M |
| December 31, 2025 | 9.310M |
| September 30, 2025 | 6.840M |
| June 30, 2025 | 6.839M |
| March 31, 2025 | 5.412M |
| December 31, 2024 | 7.339M |
| September 30, 2024 | 8.240M |
| June 30, 2024 | 8.122M |
| March 31, 2024 | 10.95M |
| December 31, 2023 | 14.92M |
| September 30, 2023 | 17.79M |
| June 30, 2023 | 20.84M |
| March 31, 2023 | 23.14M |
| December 31, 2022 | 28.06M |
| September 30, 2022 | 30.45M |
| June 30, 2022 | 34.06M |
| March 31, 2022 | 37.09M |
| December 31, 2021 | 40.58M |
| September 30, 2021 | 43.86M |
| June 30, 2021 | 20.09M |
| March 31, 2021 | 17.43M |
| December 31, 2020 | 1.778M |
| September 30, 2020 | 24.04M |
| June 30, 2020 | 21.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.64M |
| December 31, 2019 | 21.28M |
| September 30, 2019 | 30.78M |
| June 30, 2019 | 46.86M |
| March 31, 2019 | 56.62M |
| December 31, 2018 | 61.51M |
| September 30, 2018 | 71.50M |
| June 30, 2018 | 83.01M |
| March 31, 2018 | 54.15M |
| December 31, 2017 | 64.55M |
| September 30, 2017 | 72.05M |
| June 30, 2017 | 24.62M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 37.28M |
| September 30, 2015 | 40.75M |
| June 30, 2015 | 12.24M |
| March 31, 2015 | 9.946M |
| December 31, 2014 | 12.49M |
| September 30, 2014 | 9.899M |
| June 30, 2014 | 11.83M |
| March 31, 2014 | 12.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 142.97M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6154M |
| Shareholders Equity (Quarterly) | 11.37M |
| Current Ratio | 19.48 |
| Net Debt Paydown Yield | 0.00% |